Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium
Cardiovascular Radiation Medicine · 2004-07 · 5 (3) · 125-131
DOI: 10.1016/j.carrad.2004.10.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Radiation Medicine, 2004-07. Verfasst von Ron Waksman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Washington Hospital Center, Suite 4B-1, 110 Irving Street, NW, Washington, DC 20010, USA. ron.waksman@medstar.net. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Cell therapy is becoming a viable strategy to improve revascularization and myocardial function after myocardial injury. We evaluated the effect of bone marrow-derived mononuclear cell (BMMNC) transplantation on collateral vessel development and myocardial function in a porcine model of chronically infarcted heart. METHODS: Myocardial infarction was produced in 13 domestic swine. At 4 weeks, animals were randomized to receive transepicardial injections of autologous BMMNCs (approximately 24x10(6) cells, n=8) or phosphate buffered saline (PBS; control, n=5) into infarcted and border regions. Collateral growth, angiogenesis, and infarct size were assessed by angiography, immunohistochemistry, and histomorphometry. RESULTS: Regional contractility was assessed by transepicardial echocardiography at baseline and 4 weeks following treatment. Angiography revealed a trend toward increased collateral growth in the BMMNC group. Wall motion score index (myocardial function) was similar in both groups at baseline (1.63+/-0.16 vs. 1.25+/-0.25, P=.21) and at 4 weeks (1.83+/-0.22 vs. 1.63+/-0.38, P=.62). alpha-Actin-positive smooth muscle cells (SMCs) and Factor VIII positive endothelial cells were significantly greater in the BMMNC-injected animals (314.8+/-37.4/0.1 vs. 167.1+/-11.9/0.1 mm(2) in controls, P=.02, and 363.3+/-28.2 cells/0.1 mm(2) vs. 254.4+/-28.1 cells/0.1 mm(2) in controls, P=.03, respectively). The number of blood vessels >50 mum in diameter was significantly increased in the BMMNC group (317.9+/-54.9 vs. 149.1+/-6.1, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Washington Hospital Center, Suite 4B-1, 110 Irving Street, NW, Washington, DC 20010, USA. ron.waksman@medstar.net
Zitieren
APA
Waksman, R., Fournadjiev, J., Baffour, R., Pakala, R., Hellinga, D., Leborgne, L., Yazdi, H., Cheneau, E., Wolfram, R., Seabron, R., Horton, K., Kolodgie, F., Virmani, R., & Rivera, E. (2004). Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium. Cardiovascular Radiation Medicine, 5(3), 125-131. https://doi.org/10.1016/j.carrad.2004.10.001
Vancouver
Waksman R, Fournadjiev J, Baffour R, Pakala R, Hellinga D, Leborgne L, et al. Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium. Cardiovascular Radiation Medicine. 2004;5(3):125-131. doi:10.1016/j.carrad.2004.10.001
BibTeX
@article{Waksman2004,
author = {Waksman, Ron and Fournadjiev, Jana and Baffour, Richard and Pakala, Rajbabu and Hellinga, David and Leborgne, Laurent and Yazdi, Hamid and Cheneau, Edouard and Wolfram, Roswitha and Seabron, Rufus and Horton, Kenneth and Kolodgie, Frank and Virmani, Renu and Rivera, Elias},
title = {Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium},
journal = {Cardiovascular Radiation Medicine},
year = {2004},
volume = {5},
number = {3},
pages = {125--131},
doi = {10.1016/j.carrad.2004.10.001}
}
EUVIMED